Ambulatory esophageal pH monitoring: new directions.

Dig Dis

The Neuro-Enteric Clinical Research Group, Department of Medicine, Section of Gastroenterology, Southern Arizona VA Health Care System, Tucson, Arizona 85723-0001, USA.

Published: October 2006

pH testing remains a commonly used evaluative tool in clinical practice. However, the original tool that included a nasally placed pH catheter was plagued with a variety of shortcomings, primarily the effect of the procedure on patients' lifestyle and thus on reflux-provoking activities. The miniaturization of evaluative techniques in gastroenterology was the impetus for the development of the wireless pH capsule and the SmartPill. These modalities improve patients' tolerability of the required test and provide a unique opportunity for expansion of indications and data collection. The introduction of the multichannel intraluminal impedance with a pH sensor allowed the detection of gastroesophageal reflux that is non-acidic. However, the value of the technique beyond the realm of academic gastroenterology remains to be elucidated. Recently, there was a renewal of interest in Bilitec 2000. The technique, which has never found a clear clinical role, has been recommended as an important tool in evaluating patients who failed proton pump inhibitor therapy. However, data to support its clinical value in this situation have remained scant.

Download full-text PDF

Source
http://dx.doi.org/10.1159/000092885DOI Listing

Publication Analysis

Top Keywords

ambulatory esophageal
4
esophageal monitoring
4
monitoring directions
4
directions testing
4
testing remains
4
remains commonly
4
commonly evaluative
4
evaluative tool
4
tool clinical
4
clinical practice
4

Similar Publications

Background: Many patients diagnosed with gastro-oesophageal reflux disease (GERD) have persistent symptoms despite proton pump inhibitor (PPI) therapy.

Aims: The aim of this consensus is to provide evidence-based statements to guide clinicians caring for patients with refractory reflux-like symptoms (rRLS) or refractory GERD.

Methods: This consensus was developed by the International Working Group for the Classification of Oesophagitis.

View Article and Find Full Text PDF

Spirocerca lupi is a nematode typically targeting the esophageal wall but may also migrate to the spinal cord. This study aimed to characterize the clinical presentation, cerebrospinal fluid (CSF) findings, prognostic factors, and outcomes of dogs with spinal S. lupi (SSL) aberrant migration, and to evaluate prophylactic treatment efficacy.

View Article and Find Full Text PDF

Update Motility Disorders: Gastro-Oesophageal Reflux Disease - Diagnostic and Conservative Approach.

Visc Med

December 2024

Digestive Function: Basel, Laboratory and Clinic for Motility Disorders and Functional Digestive Diseases, Centre for Integrative Gastroenterology, Klinik Arlesheim, Arlesheim, Switzerland.

Background: Gastro-oesophageal reflux disease (GORD) is extremely common, with at least 1 in 10 people in the general population reporting heartburn and acid regurgitation on a weekly basis. GORD can also be associated with a variety of atypical symptoms, including chest pain, chronic cough, and laryngopharyngeal symptoms. The causes of GORD are multifactorial, and the severity of symptoms is influenced by peripheral and central factors, including psychosocial stress and anxiety.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the effects of an intensified nutrition management (iNM) protocol on patients undergoing esophagectomy for esophageal cancer, comparing it to conventional nutrition management (cNM).
  • It included 126 patients, showing that the iNM group received more frequent nutritional counseling, leading to higher compliance rates and better outcomes in body weight and skeletal muscle index (SMI) after surgery.
  • The results suggest that outpatient iNM effectively reduces body weight loss and SMI decline within 3 to 6 months post-surgery, improving overall nutritional status.
View Article and Find Full Text PDF

Comparing Participation and Interim Effectiveness of Endoscopy and Biomarker-Based Screening for Gastric Cancer: A Cluster Randomized Controlled Trial.

J Cancer

October 2024

The Department of Cancer Prevention and Control, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Prevention and Treatment Center, 283 Tongzipo Road, Changsha 410013, China.

To improve compliance with endoscopic screening for gastric cancer (GC), we assessed five biomarkers-pepsinogen I (PG I), pepsinogen II (PG II), PG I/II ratio, helicobacter pylori antibody (HP-Ab), and gastrin 17 (G17) - for secondary GC screening by comparing participation and effectiveness of traditional endoscopy and biomarker-based screening in a randomized trial with baseline results. Seventy-four communities were randomly assigned to traditional endoscopy arm (TEA) or biomarker-based endoscopy arm (BEA). TEA uses a questionnaire for risk assessment, and BEA combines a questionnaire with biomarker detection.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!